Hong‐Yi Chiu

641 total citations
14 papers, 502 citations indexed

About

Hong‐Yi Chiu is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Epidemiology. According to data from OpenAlex, Hong‐Yi Chiu has authored 14 papers receiving a total of 502 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 5 papers in Cellular and Molecular Neuroscience and 3 papers in Epidemiology. Recurrent topics in Hong‐Yi Chiu's work include Neuroscience and Neuropharmacology Research (4 papers), Pain Mechanisms and Treatments (3 papers) and Autophagy in Disease and Therapy (2 papers). Hong‐Yi Chiu is often cited by papers focused on Neuroscience and Neuropharmacology Research (4 papers), Pain Mechanisms and Treatments (3 papers) and Autophagy in Disease and Therapy (2 papers). Hong‐Yi Chiu collaborates with scholars based in Taiwan and India. Hong‐Yi Chiu's co-authors include Jai‐Sing Yang, Fuu‐Jen Tsai, Yuan‐Man Hsu, Chi‐Cheng Lu, Jo‐Hua Chiang, Yu‐Ning Juan, Chih‐Chia Lai, Hsun‐Hsun Lin, Da‐Tian Bau and Liang‐Chun Shih and has published in prestigious journals such as Neuropharmacology, Neuroreport and The International Journal of Neuropsychopharmacology.

In The Last Decade

Hong‐Yi Chiu

14 papers receiving 497 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Hong‐Yi Chiu Taiwan	13	243	63	62	59	50	14	502
Bruna Girardi Italy	16	236 1.0×	56 0.9×	51 0.8×	84 1.4×	84 1.7×	35	761
Krishnendu Ganguly India	10	211 0.9×	99 1.6×	43 0.7×	67 1.1×	82 1.6×	19	698
Gaurav Kaushik United States	14	362 1.5×	115 1.8×	33 0.5×	92 1.6×	48 1.0×	20	644
Francheska Colón‐González United States	12	307 1.3×	22 0.3×	54 0.9×	43 0.7×	94 1.9×	19	596
Xingyong Chen China	14	193 0.8×	47 0.7×	28 0.5×	33 0.6×	56 1.1×	27	600
Terézia Kisková Slovakia	14	261 1.1×	82 1.3×	28 0.5×	62 1.1×	101 2.0×	38	577
Qing Ye China	15	183 0.8×	49 0.8×	41 0.7×	23 0.4×	29 0.6×	35	516
Tayyiba Akbar Ali Qatar	8	278 1.1×	45 0.7×	32 0.5×	56 0.9×	61 1.2×	12	518
Ke Mao China	14	258 1.1×	84 1.3×	48 0.8×	43 0.7×	140 2.8×	31	583

Countries citing papers authored by Hong‐Yi Chiu

Since Specialization

Citations

This map shows the geographic impact of Hong‐Yi Chiu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hong‐Yi Chiu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hong‐Yi Chiu more than expected).

Fields of papers citing papers by Hong‐Yi Chiu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hong‐Yi Chiu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hong‐Yi Chiu. The network helps show where Hong‐Yi Chiu may publish in the future.

Co-authorship network of co-authors of Hong‐Yi Chiu

This figure shows the co-authorship network connecting the top 25 collaborators of Hong‐Yi Chiu. A scholar is included among the top collaborators of Hong‐Yi Chiu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hong‐Yi Chiu. Hong‐Yi Chiu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Chiu, Hong‐Yi, Shih‐Chang Tsai, Fuu‐Jen Tsai, et al.. (2023). Liraglutide With Metformin Therapy Ameliorates Hepatic Steatosis and Liver Injury in a Mouse Model of Non-alcoholic Steatohepatitis. In Vivo. 37(3). 1037–1046. 5 indexed citations

Chiu, Yu‐Jen, Jai‐Sing Yang, Fuu‐Jen Tsai, et al.. (2022). Curcumin suppresses cell proliferation and triggers apoptosis in vemurafenib‐resistant melanoma cells by downregulating the EGFR signaling pathway. Environmental Toxicology. 37(4). 868–879. 30 indexed citations

CHANG, WEN-SHIN, Chia‐Wen Tsai, Jai‐Sing Yang, et al.. (2021). Resveratrol inhibited the metastatic behaviors of cisplatin‐resistant human oral cancer cells via phosphorylation of ERK/p‐38 and suppression of MMP‐2/9. Journal of Food Biochemistry. 45(6). e13666–e13666. 116 indexed citations

Tsai, Shih‐Chang, Chi‐Cheng Lu, DA-TIAN BAU, et al.. (2020). Approaches towards fighting the COVID‑19 pandemic (Review). International Journal of Molecular Medicine. 47(1). 3–22. 45 indexed citations

Chiang, Jo‐Hua, Fuu‐Jen Tsai, Yuan‐Man Hsu, et al.. (2020). Sensitivity of allyl isothiocyanate to induce apoptosis via ER stress and the mitochondrial pathway upon ROS production in colorectal adenocarcinoma cells. Oncology Reports. 44(4). 1415–1424. 27 indexed citations

Lu, Chi‐Cheng, Jo‐Hua Chiang, Fuu‐Jen Tsai, et al.. (2019). Metformin triggers the intrinsic apoptotic response in human AGS gastric adenocarcinoma cells by activating AMPK and suppressing mTOR/AKT signaling. International Journal of Oncology. 54(4). 1271–1281. 63 indexed citations

Chen, Chin‐Fu, Jai‐Sing Yang, Wen‐Kang Chen, et al.. (2018). Ursolic acid elicits intrinsic apoptotic machinery by downregulating the phosphorylation of AKT/BAD signaling in human cisplatin‑resistant oral cancer CAR cells. Oncology Reports. 40(3). 1752–1760. 18 indexed citations

Chen, Chin‐Fu, Chi‐Cheng Lu, Jo‐Hua Chiang, et al.. (2018). Synergistic inhibitory effects of cetuximab and curcumin on human cisplatin‑resistant oral cancer CAR cells through intrinsic apoptotic process. Oncology Letters. 16(5). 6323–6330. 34 indexed citations

Horng, Chi‐Ting, Chi‐Cheng Lu, Chen‐Ying Su, et al.. (2018). Kaempferol inhibits angiogenic ability by targeting VEGF receptor-2 and downregulating the PI3K/AKT, MEK and ERK pathways in VEGF-stimulated human umbilical vein endothelial cells. Oncology Reports. 39(5). 2351–2357. 69 indexed citations

10.

Chiu, Hong‐Yi, et al.. (2014). Long-lasting alterations in 5-HT2A receptor after a binge regimen of methamphetamine in mice. The International Journal of Neuropsychopharmacology. 17(10). 1647–1658. 25 indexed citations

11.

Chiu, Hong‐Yi, et al.. (2014). N-acetylcysteine modulates hallucinogenic 5-HT2A receptor agonist-mediated responses: Behavioral, molecular, and electrophysiological studies. Neuropharmacology. 81. 215–223. 16 indexed citations

12.

Chiu, Hong‐Yi, Hsun‐Hsun Lin, & Chih‐Chia Lai. (2010). Cocaine- and amphetamine-regulated transcript (CART) peptide activates ERK pathways via NMDA receptors in rat spinal cord dorsal horn in an age-dependent manner. Regulatory Peptides. 164(2-3). 90–96. 13 indexed citations

13.

Chiu, Hong‐Yi, Hsun‐Hsun Lin, & Chih‐Chia Lai. (2009). Potentiation of spinal NMDA-mediated nociception by cocaine- and amphetamine-regulated transcript peptide via PKA and PKC signaling pathways in rats. Regulatory Peptides. 158(1-3). 77–85. 22 indexed citations

14.

Lin, Hsun‐Hsun, Hong‐Yi Chiu, & Chih‐Chia Lai. (2005). Potentiation of spinal N-methyl-D-aspartate-mediated nociceptive transmission by cocaine-regulated and amphetamine-regulated transcript peptide in rats. Neuroreport. 16(3). 253–257. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact